| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 1.713 | 22.086 | 32.154 | 115.466 | 327.501 |
| Total Income - EUR | - | - | - | - | - | 1.713 | 22.086 | 32.154 | 115.466 | 327.501 |
| Total Expenses - EUR | - | - | - | - | - | 12 | 345 | 272 | 9.394 | 142.460 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.701 | 21.742 | 31.882 | 106.071 | 185.041 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.650 | 21.079 | 30.917 | 104.917 | 175.216 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Sinopsis Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 25 | 25 | 3.340 | 4.518 | 56.909 |
| Current Assets | - | - | - | - | - | 1.748 | 21.666 | 28.559 | 127.321 | 192.074 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 6.851 |
| Receivables | - | - | - | - | - | 411 | 10.031 | 3.244 | 91.761 | 41.421 |
| Cash | - | - | - | - | - | 1.337 | 11.635 | 25.314 | 35.560 | 143.802 |
| Shareholders Funds | - | - | - | - | - | 1.691 | 21.135 | 31.325 | 127.928 | 200.694 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 82 | 555 | 574 | 3.910 | 48.289 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sinopsis Medical S.r.l.